SCHEMBL17501260

SCHEMBL17501260

C=CCS(=O)O.[NaH]

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1139865 0.97
SCHEMBL3240865 0.71
Sulfurous Acid SCHEMBL27897276 0.69
SCHEMBL23829641 0.67
SCHEMBL5794937 0.67
SCHEMBL10776738 0.67 MEN1 (0.33)
Sulfurous Acid SCHEMBL25287274 0.67
SCHEMBL10012479 0.67
SCHEMBL25453246 0.65
Allylamine SCHEMBL7866713 0.65

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110511166-A A kind of synthetic method of two arylmethyls alkyl sulfone UNIV CHENGDU TECHNOLOGY 2019-11-29 CN claimed
CN-106631926-B A kind of method of selectivity synthesis aryl methyl sulfone and beta-hydroxylic sulfone derivation 华南理工大学 2018-12-14 CN claimed
CN-106631926-A Method for selectively compounding aryl methyl sulphone and belta-hydroxy sulphone derivative 华南理工大学 2017-05-10 CN claimed
US-11529356-B2 2-(morpholin-4-yl)-1,7-naphthyridines BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2022-12-20 US disclosed
CN-110204544-B 2- (morpholin-4-yl) -1, 7-naphthyridine 拜耳制药股份公司 2022-04-12 CN disclosed
CN-110256427-B 2- (morpholin-4-yl) -1, 7-naphthyridine 拜耳制药股份公司 2022-02-22 CN disclosed
CN-108699057-B 5-substituted 2- (morpholin-4-yl) -1, 7-naphthyridines 拜耳医药股份公司 2021-11-09 CN disclosed
EP-3395818-B1 2-(MORPHOLIN-4-YL)-1,7-NAPHTHYRIDINES Bayer Pharma AG (DE) 2021-09-22 EP disclosed
US-20200383991-A1 2-(MORPHOLIN-4-YL)-1,7-NAPHTHYRIDINES BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2020-12-10 US disclosed
US-10772893-B2 2-(morpholin-4-yl)-1,7-naphthyridines BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2020-09-15 US disclosed
US-10729680-B2 5-substituted 2-(morpholin-4-yl)-1,7-naphthyridines BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2020-08-04 US disclosed
WO-2017121684-A1 5-SUBSTITUTED 2-(MORPHOLIN-4-YL)-1,7-NAPHTHYRIDINES BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2017-07-20 WO disclosed
EP-3177619-A1 2-(MORPHOLIN-4-YL)-1,7-NAPHTHYRIDINES Bayer Pharma Aktiengesellschaft (DE) 2017-06-14 EP disclosed
CN-106795156-A 2- (morpholin-4-yl) -1, 7-naphthyridine 拜耳制药股份公司 2017-05-31 CN disclosed
CN-106631926-A Method for selectively compounding aryl methyl sulphone and belta-hydroxy sulphone derivative 华南理工大学 2017-05-10 CN disclosed
US-9549932-B2 2-(morpholin-4-yl)-1,7-naphthyridines BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2017-01-24 US disclosed
US-20160287604-A1 2-(MORPHOLIN-4-YL)-1,7-NAPHTHYRIDINES BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2016-10-06 US disclosed
CN-105829285-A Quinazolinone and isoquinolinone derivatives 中外制药株式会社 2016-08-03 CN disclosed
WO-2016020320-A1 2-(MORPHOLIN-4-YL)-L,7-NAPHTHYRIDINES BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2016-02-11 WO disclosed
CN-104114614-A COLD-BOX BINDING AGENT SYSTEMS AND MIXTURES FOR USE AS ADDITIVES FOR SUCH BINDING AGENT SYSTEMS HUETTENES ALBERTUS 2014-10-22 CN disclosed